Quantitative Systematic Strategies’s Travere Therapeutics TVTX Stock Holding History

Quantitative Systematic Strategies’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-26,818	Closed	-$731K	–	769
2020 Q4	$731K	Buy	+26,818	New	+$626K	0.1%	310
2019 Q2	–	Sell	-9,911	Closed	-$224K	–	576
2019 Q1	$224K	Sell	9,911 -13,402	-57%	-$296K	0.06%	303
2018 Q4	$528K	Buy	23,313 +10,760	+86%	+$268K	0.12%	261
2018 Q3	$361K	Buy	+12,553	New	+$359K	0.07%	374
2018 Q2	–	Sell	-10,974	Closed	-$245K	–	796
2018 Q1	$245K	Buy	+10,974	New	+$261K	0.05%	513
2016 Q1	–	Sell	-26,344	Closed	-$518K	–	758
2015 Q4	$518K	Buy	+26,344	New	+$526K	0.14%	180

Other funds holding TVTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Quantitative Systematic Strategies's TVTX Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of Travere Therapeutics (TVTX) in Q1 2021, closing a stake of 26,818 shares — an estimated $731K sold.

Quantitative Systematic Strategies first reported a position in TVTX in Q4 2015 and held it in 6 quarters. The position peaked at $731K in Q4 2020. 150 funds tracked by Wall St. Rank hold TVTX as of Q1 2021.

Quantitative Systematic Strategies reported no remaining Travere Therapeutics position as of Q1 2021 after selling out during the quarter.
Quantitative Systematic Strategies sold 26,818 Travere Therapeutics shares in Q1 2021, an estimated $731K.
Quantitative Systematic Strategies first reported a position in Travere Therapeutics in Q4 2015 and held it in 6 quarters.
Quantitative Systematic Strategies's Travere Therapeutics position peaked at $731K in Q4 2020.
150 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.